SCHEMBL21254262

SCHEMBL21254262

CCOc1ccc(C2=Cc3ccc4c(c3OC2)C=CC(C)(C)O4)c(OS(=O)(=O)c2ccc(C)cc2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYR P14679 1/20 0.38
▸ ODC1 P11926 1/20 0.36
▸ CYP3A4 P08684 3/20 0.34
▸ MAPT P10636 3/20 0.34
▸ TP53 P04637 2/20 0.34
▸ CYP1A2 P05177 2/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ LMNA P02545 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ CNR2 P34972 3/20 0.33
▸ GAA P10253 3/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21254071 0.94 TYR (0.37) TYRODC1CYP3A4MAPTTP53
SCHEMBL21254269 0.94 TYR (0.37) TYRODC1CYP3A4MAPTTP53
SCHEMBL21254126 0.91 ACHE (0.41) TYRODC1CYP3A4MAPTTP53
SCHEMBL20051755 0.91 TYR (0.36) TYRODC1CYP3A4MAPTTP53
SCHEMBL20051692 0.89 TYR (0.39) TYRODC1CYP3A4MAPTTP53
SCHEMBL20051767 0.88 TYR (0.38) TYRODC1CYP3A4MAPTTP53
SCHEMBL20051836 0.88 TYR (0.36) TYRODC1CYP3A4MAPTTP53
SCHEMBL20051750 0.87 CNR2 (0.40) TYRODC1CYP3A4MAPTTP53
SCHEMBL23398012 0.86 CNR2 (0.42) TYRODC1CYP3A4MAPTTP53
SCHEMBL20051754 0.86 L3MBTL1 (0.33) CYP3A4MAPTCYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524609-B1 PROCESS FOR THE PREPARATION OF 3-PHENYL-2,3,4,8,9,10-HEXAHYDROPYRANO[2,3-F]CHROMENE DERIVATIVES, OPTICAL ISOMERS THEREOF, AND INTERMEDIATES OF THE PROCESS GLACEUM INC (KR) 2021-05-26 — — EP disclosed
US-10947250-B2 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivative and method for synthesizing optical isomer thereof GLACEUM, INC. 2021-03-16 — — US disclosed
US-20210040106-A1 METHOD FOR SYNTHESIZING 3-PHENYL-2,8-DIHYDROPYRANO [2,3-F] CHROMENE DERIVATIVE Glaceum Inc. (KR) 2021-02-11 — — US disclosed
US-20200199142-A1 3-PHENYL-2,3,4,8,9,10-HEXAHYDROPYRANO[2,3-F]CHROMENE DERIVATIVE AND METHOD FOR SYNTHESIZING OPTICAL ISOMER THEREOF GLACEUM INC (KR) 2020-06-25 — — US disclosed
US-10669282-B2 Method for synthesizing 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2.3-f]chromene derivative and optical isomer of thereof GLACEUM, INC. (KR) 2020-06-02 — — US disclosed
US-20200048272-A1 3-PHENYL-2,3,4,8,9,10-HEXAHYDROPYRANO[2,3-F]CHROMENE DERIVATIVE AND METHOD FOR SYNTHESIZING OPTICAL ISOMER THEREOF GLACEUM, INC. (KR) 2020-02-13 — — US disclosed
WO-2019194582-A1 METHOD FOR SYNTHESIZING 3-PHENYL-2,8-DIHYDROPYRANO [2,3-F] CHROMENE DERIVATIVE 주식회사 글라세움 2019-10-10 — — WO disclosed
EP-3524609-A1 3-PHENYL-2,3,4,8,9,10-HEXAHYDROPYRANO[2,3-F]CHROMENE DERIVATIVE AND METHOD FOR SYNTHESIZING OPTICAL ISOMER THEREOF Glaceum, Inc. (KR) 2019-08-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10669282-B2 Method for synthesizing 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2.3-f]chromene derivative and optical isomer of thereof CYP2J2, CYP2A13, HPD TYR 23/4885ODC1 1009/4885CYP3A4 28/4885
US-20200199142-A1 3-PHENYL-2,3,4,8,9,10-HEXAHYDROPYRANO[2,3-F]CHROMENE DERIVATIVE AND METHOD FOR SYNTHESIZING OPTICAL ISOMER THEREOF CYP2J2, HPD, CYP2A13 TYR 53/4885ODC1 1888/4885CYP3A4 27/4885
US-20200048272-A1 3-PHENYL-2,3,4,8,9,10-HEXAHYDROPYRANO[2,3-F]CHROMENE DERIVATIVE AND METHOD FOR SYNTHESIZING OPTICAL ISOMER THEREOF CYP2J2, HPD, CYP2A13 TYR 53/4885ODC1 1888/4885CYP3A4 27/4885
US-10947250-B2 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivative and method for synthesizing optical isomer thereof CYP2J2, HPD, CYP2A13 TYR 53/4885ODC1 1888/4885CYP3A4 27/4885
US-20210040106-A1 METHOD FOR SYNTHESIZING 3-PHENYL-2,8-DIHYDROPYRANO [2,3-F] CHROMENE DERIVATIVE HPD, CYP2J2, PAH TYR 12/4885ODC1 2294/4885CYP3A4 82/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback